Sermorelin has a documented regulatory history, but that history needs precise wording. FDA records describe earlier Geref products with specific pediatric treatment and diagnostic indications. Their discontinuation and later regulatory review should not be collapsed into a simple claim that all sermorelin products are either approved or unsafe.

In a 2013 notice, FDA determined that the specified Geref products had not been withdrawn from sale for reasons of safety or effectiveness. The notice also describes the earlier withdrawal of their approvals and explains the implications for potential generic applications meeting other requirements. FDA Geref discontinuation determination

A historical determination has a limited meaning

The finding addresses why those products were withdrawn. It is not a new approval for contemporary compounded preparations, research vials or adult wellness uses. It also does not establish that every use of the molecule has been evaluated.

A product-specific approval concerns a defined formulation and indication. FDA’s explanation of approval claims reinforces why a molecular name or administrative record should not be treated as a general endorsement. FDA explanation of approval claims

Match the claim to the evidence

A claim about adult body composition, recovery or anti-aging would need appropriate evidence in that population and for that outcome. Historical pediatric growth-hormone-deficiency evidence does not automatically answer those questions. Hormone measurements also should not be substituted for functional or long-term health benefits.

A careful review should identify the exact product, regulatory record and clinical study being discussed. If the article concerns a current compounded product, its status and quality need to be evaluated separately from the historical brand.

AXON’s conclusion is that sermorelin’s history is informative but not a shortcut. The useful educational task is to preserve the distinctions among historical approval, discontinuation, compounding and unproven expanded claims. This article provides no dosing or administration guidance and makes no recommendation for wellness use.